TASIMELTEON

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C15H19NO2
Molecular Weight	245.3169
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of TASIMELTEON

Structure Search

SMILES

CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2

InChI

InChIKey=PTOIAAWZLUQTIO-GXFFZTMASA-N

InChI=1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1

HIDE SMILES / InChI

Molecular Formula	C15H19NO2
Molecular Weight	245.3169
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:58:06 UTC 2023` Edited by `admin` on `Fri Dec 15 15:58:06 UTC 2023`
Record UNII	SHS4PU80D9
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TASIMELTEON

Official Name

English

TASIMELTEON [USAN]

Common Name

English

HETLIOZ

Brand Name

English

Tasimelteon [WHO-DD]

Common Name

English

PROPANAMIDE, N-(((1R,2R)-2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL)METHYL)-

Systematic Name

English

BMS-214778

Code

English

VEC-162

Code

English

BMS-214,778

Code

English

HETLIOZ LQ

Brand Name

English

N-[[(1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide

Systematic Name

English

TASIMELTEON [VANDF]

Common Name

English

TASIMELTEON [MI]

Common Name

English

TASIMELTEON [MART.]

Common Name

English

TASIMELTEON [ORANGE BOOK]

Common Name

English

tasimelteon [INN]

Common Name

English

Classification Tree Code System Code

WHO-ATC

N05CH03

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

NDF-RT

N0000175743

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

FDA ORPHAN DRUG

297409

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

EU-Orphan Drug

EU/3/10/841

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

EMA ASSESSMENT REPORTS

HETLIOZ (AUTHORIZED: SLEEP DISORDERS, CICARDIAN RHYTHM)

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

NCI_THESAURUS

C47795

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

FDA ORPHAN DRUG

301410

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

Code System Code Type Description

USAN

SS-70

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

DAILYMED

SHS4PU80D9

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

FDA UNII

SHS4PU80D9

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

PUBCHEM

10220503

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

CAS

609799-22-6

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

IUPHAR

7393

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

EPA CompTox

DTXSID70209826

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

CHEBI

79042

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

RXCUI

1490468

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

RxNorm

NCI_THESAURUS

C152515

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

SMS_ID

100000157714

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

DRUG CENTRAL

4820

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

MERCK INDEX

m10478

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

Merck Index

INN

8985

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

EVMPD

SUB166225

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

ChEMBL

CHEMBL2103822

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

DRUG BANK

DB09071

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

WIKIPEDIA

TASIMELTEON

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

MESH

C478745

Created by admin on Fri Dec 15 15:58:06 UTC 2023 , Edited by admin on Fri Dec 15 15:58:06 UTC 2023

PRIMARY

Related Record Type Details


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR


					SHS4PU80D9

EXCRETED UNCHANGED

Qualification:

FECAL

Amount:


					RES3V2K0VC

MELATONIN MT2 RECEPTOR

TARGET -> AGONIST


					VK4SQL11C0

CYTOCHROME P450 1A2

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					SHS4PU80D9

EXCRETED UNCHANGED

Qualification:

URINE

Amount:


					9DX651UO0D

CYTOCHROME P450 1A1

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR


					C23A33SC67

MELATONIN MT1 RECEPTOR

TARGET -> AGONIST


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MINOR

Related Record Type Details


					UH8466QZ6U

2-(2-HYDROXY-6-((1R,2R)-2-(PROPIONAMIDOMETHYL)CYCLOPROPYL)PHENYL)ACETIC ACID

METABOLITE INACTIVE -> PARENT

Interaction Type:

MAJOR


					KJ8GMM2HWE

(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-((4-((1R,2R)-2-((PROPANOYLAMINO)METHYL)CYCLOPROPYL)-2,3-DIHYDROBENZOFURAN-2-YL)OXY)TETRAHYDROPYRAN-2-CARBOXYLIC ACID

METABOLITE -> PARENT


					YTL2HM2EPM

2-HYDROXY TASIMELTEON, (2S)-

METABOLITE -> PARENT


					UH8466QZ6U

2-(2-HYDROXY-6-((1R,2R)-2-(PROPIONAMIDOMETHYL)CYCLOPROPYL)PHENYL)ACETIC ACID

METABOLITE -> PARENT


					4E33W6K5P4

(2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(2-(2-HYDROXYETHYL)-3-((1R,2R)-2-((PROPANOYLAMINO)METHYL)CYCLOPROPYL)PHENOXY)TETRAHYDROPYRAN-2-CARBOXYLIC ACID

METABOLITE -> PARENT

Related Record Type Details


					SHS4PU80D9

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC				SINGLE- OR MULTIPLE-DOSE ADMINISTRATION

Volume of Distribution	PHARMACOKINETIC

Biological Half-life	PHARMACOKINETIC